CAS 65004-42-4

Formel: C10H12N4O

InChl: InChI=1S/C10H12N4O/c1-6-5-9(15)12-10(11-6)14-8(3)4-7(2)13-14/h4-5H,1-3H3,(H,11,12,15)

InChI Key: XIFVEJXUSTTZKD-UHFFFAOYSA-N

SMILES: CC1=CC(=O)NC(=N1)N2C(=CC(=N2)C)C

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4(3H)-one

CAS: 65004-42-4

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4(3H)-one

Formel: C₁₀H₁₂N₄O

Reinheit: 97%

Molekulargewicht: 204.23

Ref: 54-OR1058071

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4(3H)-one

CAS: 65004-42-4

Reinheit: 97%

Ref: IN-DA01B7IO

Pyrimidinone 8

CAS: 65004-42-4

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4(3H)-one

Formel: C₁₀H₁₂N₄O

Reinheit: 97%

Molekulargewicht: 204.23

Ref: IN-DG303254

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-ol

CAS: 65004-42-4

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-ol is a tautomeric form of 2-(3,5-dimethylpyrazol-1-yl)-6-[(2R,3S)-3,5-dimethoxyphenyl]pyrimidin-4-ol. It is a potent inhibitor of lipases and has been shown to have antiinflammatory properties. The drug has also been found to decrease the number of inflammatory cells in the bowel and can be used for the treatment of inflammatory bowel disease. The drug may also be effective for treating other autoimmune diseases such as thyroiditis and scleroderma. This drug also has cancer prevention effects because it inhibits cell division and tumor growth by binding to DNA.

Formel: C₁₀H₁₂N₄O

Reinheit: Min. 95%

Molekulargewicht: 204.23 g/mol

Ref: 3D-QCA00442

Pyrimidinone 8

CAS: 65004-42-4

Pyrimidinone 8 is a reversible, linear non-competitive inhibitor of divalent metal transporter 1 (DMT1) with a Ki of 20 μM (hDMT1). It does not affect the surface expression of hDMT1 and is not influenced by extracellular pH. Pyrimidinone 8 inhibits hDMT1-mediated iron uptake, with an IC50 of 13.8 μM.

Formel: C₁₀H₁₂N₄O

Farbe und Form: Solid

Molekulargewicht: 204.229

Ref: TM-T205042